Procter & Gamble Health Ltd: Stock Analysis & Fundamentals

Updated this week

Procter & Gamble Health Ltd (Pharma - MNC bulk Drugs) — fundamental analysis, earnings data, and key metrics. PE: 27.5. ROE: 36.4%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

💪Debt reduced 40% YoY — balance sheet strengthening

🌐FII stake increased 0.6% this quarter

Key Numbers

Current Price

₹4,857

Dividend Yield

2.57%

Market Cap

8.1K Cr

Valuation

N/A

Other Top Pharma - MNC bulk Drugs Stocks Beating Nifty 500

Novartis India Ltd

Weak • 6w streak

+36.4%

← Back to Pharma - MNC bulk Drugs Dashboard

Frequently Asked Questions: Procter & Gamble Health Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Procter & Gamble Health Ltd's latest quarterly results?

Procter & Gamble Health Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: -14.3%
Revenue Growth YoY: +20.6%
Operating Margin: 30.0%

What is Procter & Gamble Health Ltd's current PE ratio?

Procter & Gamble Health Ltd's current PE ratio is 27.5x.

Current PE: 27.5x
Market Cap: 8.1K Cr
Dividend Yield: 2.57%

What is Procter & Gamble Health Ltd's price-to-book ratio?

Procter & Gamble Health Ltd's price-to-book ratio is 13.0x.

Price-to-Book (P/B): 13.0x
Book Value per Share: ₹373
Current Price: ₹4857

Is Procter & Gamble Health Ltd a fundamentally strong company?

Procter & Gamble Health Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 48.0%

Is Procter & Gamble Health Ltd debt free?

Procter & Gamble Health Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹6 Cr

What is Procter & Gamble Health Ltd's return on equity (ROE) and ROCE?

Procter & Gamble Health Ltd's return ratios over recent years

Jun 2023: ROCE 45.0%
Jun 2024: ROCE 45.0%
FY2025: ROCE 48.0%

Is Procter & Gamble Health Ltd's cash flow positive?

Procter & Gamble Health Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹169 Cr
Free Cash Flow (FCF): ₹179 Cr
CFO/PAT Ratio: 72% (adequate)

What is Procter & Gamble Health Ltd's dividend yield?

Procter & Gamble Health Ltd's current dividend yield is 2.57%.

Dividend Yield: 2.57%
Current Price: ₹4857

Who holds Procter & Gamble Health Ltd shares — promoters, FII, DII?

Procter & Gamble Health Ltd's shareholding pattern (Dec 2025)

Promoters: 51.8%
FII (Foreign): 7.0%
DII (Domestic): 13.8%
Public: 27.4%

Is promoter holding increasing or decreasing in Procter & Gamble Health Ltd?

Procter & Gamble Health Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 51.8% (Dec 2025)
Previous Quarter: 51.8% (Sep 2025)
Change: 0.00% (stable)

Is Procter & Gamble Health Ltd a new momentum entry or an established outperformer?

Procter & Gamble Health Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Procter & Gamble Health Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Procter & Gamble Health Ltd may be worth studying

Cash flow is positive — CFO ₹169 Cr

What is the investment thesis for Procter & Gamble Health Ltd?

Procter & Gamble Health Ltd investment thesis summary:

What is the future outlook for Procter & Gamble Health Ltd?

Procter & Gamble Health Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.